For children with rare, aggressive and advanced cancer, precision medicine may help doctors determine their best treatment options, a new study finds. Using information from a patient’s entire genome helped suggest personalized treatment options for nearly half of children with cancer, and led to specific treatment changes in a quarter of these patients.
A new marker already linked to other types of cancer was found to play a role in retinoblastoma, a rare but lethal form of cancer. When advanced forms of RB affect both eyes, this cancer causes partial or full loss of vision in about 50 percent of patients. This tumor is normally treated by eye removal or administration of chemotherapy drugs that are often toxic to the normal retina, and thus can jeopardize vision. No targeted therapy, which selectively kills tumor cells but spares normal retinal cells, exists.
Concerns about fertility kept a third of young women with breast cancer from taking tamoxifen, despite its known benefit in reducing the risk of breast cancer coming back.
Diane Simeone, M.D., director of the Pancreatic Cancer Center at the University of Michigan, was recently named the upcoming chair of the National Scientific and Medical Advisory Board for the Pancreatic Cancer Action Network.
The University of Michigan Comprehensive Cancer Center’s Breast Oncology Program was one of nine beneficiaries of the 2014 QVC Presents "FFANY Shoes on Sale" event. FFANY and QVC representatives presented a check for $380,000 to the Cancer Center.
Andrew D. Rhim, M.D., assistant professor of gastroenterology, received a 2015 Clinical Scientist Development Award from the Doris Duke Charitable Foundation to advance research on pancreatic cancer.
Cancerous tumors cast off tiny telltale genetic molecules known as microRNAs and a team of University of Michigan researchers has come up with an efficient way to detect them in blood.
President Barack Obama announced his selection of Max S. Wicha, M.D., as one of five new appointees to the National Cancer Advisory Board.
A new study suggests that fusion of one normal cell with another — as observed in inflammation, infection, and injury from carcinogens — triggers a “genomic catastrophe” that converts normal cells to cancer cells and enables tumors to form.
Cancer Center researchers presented on care coordination and quality of care in colorectal cancer, imaging to predict sarcoma treatment, using serial biopsies to find aggressive prostate cancer, and side effects of oral chemotherapy at the American Society of Clinical Oncology annual meeting.